Drug Delivery Most Volatile: Delcath Systems (NASDAQ:DCTH), Bio-Path Holdings (NASDAQ:BPTH), Flamel Technologies (NASDAQ:FLML), Adamis Pharmaceuticals (NASDAQ:ADMP)

Wall Street flees from troubled Delcath Systems Inc. (NASDAQ:DCTH) after the cancer-treatment devices maker proceeds with a 1-to-16 reverse stock split. Delcath Systems, Inc. (NASDAQ:DCTH) stock performance was -20.30% in last session and finished the day at $3.73. Traded volume was 1.19million shares in the last session and the average volume of the stock remained 302.19K shares. The beta of the stock remained 2.55. Delcath … Continue reading Drug Delivery Most Volatile: Delcath Systems (NASDAQ:DCTH), Bio-Path Holdings (NASDAQ:BPTH), Flamel Technologies (NASDAQ:FLML), Adamis Pharmaceuticals (NASDAQ:ADMP)

Kristen Barton04/1004/10

Investors Watch List: Cisco Systems (NASDAQ:CSCO), Bio-Path Inc. (NASDAQ:BPTH), EQT Corporation (NYSE:EQT), Rare Element Resources (NYSEMKT: REE), Align (NASDAQ:ALGN)

On 13 AUG Cisco Systems, Inc. (NASDAQ:CSCO) last issued its quarterly earnings data on Wednesday. The company reported $0.55 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.53 by $0.02. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $12.14 billion. Analysts expect that Cisco Systems will post $2.16 EPS for the current fiscal … Continue reading Investors Watch List: Cisco Systems (NASDAQ:CSCO), Bio-Path Inc. (NASDAQ:BPTH), EQT Corporation (NYSE:EQT), Rare Element Resources (NYSEMKT: REE), Align (NASDAQ:ALGN)

Jayne Crisman08/18

Trending Stocks :Allscripts Healthcare Solutions (NASDAQ:MDRX), Amkor (NASDAQ:AMKR), Great Panther Silver (NYSEMKT:GPL), Bio-Path Holdings, Inc. (NASDAQ:BPTH), Electronics (NASDAQ:EFII)

Allscripts (NASDAQ: MDRX) announced today that it will integrate Clinical Architecture’s comprehensive terminology management system, Symedical®, with the Allscripts dbMotion? health information exchange platform for enhanced vocabulary management. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) belongs to Technology sector. Its net profit margin is -8.30% and weekly performance is -9.10%. On last trading day company shares ended up $13.98. Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) distance from 50-day … Continue reading Trending Stocks :Allscripts Healthcare Solutions (NASDAQ:MDRX), Amkor (NASDAQ:AMKR), Great Panther Silver (NYSEMKT:GPL), Bio-Path Holdings, Inc. (NASDAQ:BPTH), Electronics (NASDAQ:EFII)

Jayne Crisman08/14

Morning Alert – IAMGOLD (NYSE:IAG), Goldcorp (NYSE:GG), Porter Bancorp (NASDAQ:PBIB), BankFinancial (NASDAQ:BFIN), Bio-Path Holdings (NASDAQ:BPTH)

IAMGOLD Corp (USA) (NYSE:IAG) on June 23 provided an update from ongoing exploration activities at the Company’s 100%-owned Pitangui gold project located approximately 110 kilometres northwest of Belo Horizonte , the capital city of Minas Gerais State, Brazil . The project comprises 180.3 square kilometres of exploration licenses covering the Archean Pitangui greenstone belt where an estimated inferred resource of 4.07 million tonnes grading 4.88 … Continue reading Morning Alert – IAMGOLD (NYSE:IAG), Goldcorp (NYSE:GG), Porter Bancorp (NASDAQ:PBIB), BankFinancial (NASDAQ:BFIN), Bio-Path Holdings (NASDAQ:BPTH)

Mark Doerr07/18

Drug Stocks: Valeant Pharmaceuticals (NYSE:VRX), Bio-Path Holdings Inc (NASDAQ:BPTH), Alkermes (NASDAQ:ALKS), Petmed Express Inc (NASDAQ:PETS), Acura Pharmaceuticals (NASDAQ:ACUR)

JUST after Valeant Pharmaceuticals International Inc (NYSE:VRX) bought Medicis Pharmaceutical two years ago, the new owner gathered staff of the skin-products maker and started handing out envelopes. If you got a black envelope, it meant you were fired. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) stock performance was -0.29% in last session and finished the day at $125.18. Traded volume was 3.08million shares in the last session … Continue reading Drug Stocks: Valeant Pharmaceuticals (NYSE:VRX), Bio-Path Holdings Inc (NASDAQ:BPTH), Alkermes (NASDAQ:ALKS), Petmed Express Inc (NASDAQ:PETS), Acura Pharmaceuticals (NASDAQ:ACUR)

Jason Knox06/12